Pipeline – PLX-PAD

*One Multinational trial – U.S. – Phase III, Europe- via adaptive pathway allowing early conditional marketing approval

**Pending FDA/EMA approval

Critical Limb Ischemia

Intermittent Claudication

Orthopedic Indications